Opportunity Information: Apply for PAR 23 163
The National Institutes of Health (NIH) grant opportunity PAR-23-163, titled "Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed)," supports institutional T32 training programs aimed at building the workforce needed to move Alzheimer’s and related dementias research from basic discovery toward therapies. This notice is a reissue of PAR-21-112, with an important administrative update: it explicitly adds the option to apply as a renewal (in addition to other allowed application types) in the relevant sections of the funding announcement. The overall focus remains the same, but the renewal option is meant to help successful programs continue and expand their training efforts.
The core purpose of this program is workforce development in translational AD/ADRD research, spanning the full pipeline from target discovery through clinical development. NIH is looking for programs that can prepare scientists to work across disciplines rather than staying in narrow silos. The emphasis is on cultivating a diverse and interdisciplinary pool of trainees who can connect basic biology to translational work and ultimately to clinically relevant outcomes. While the mechanism is a training grant (T32), the opportunity explicitly indicates "Clinical Trial Not Allowed," meaning the supported training activities should not include conducting independent clinical trials under this award, even though trainees may learn clinical research methods and work with clinical data or preclinical-to-clinical translation topics as part of their training.
The funded programs are expected to train both predoctoral and postdoctoral researchers and to recruit trainees with varied educational and technical backgrounds. The announcement highlights a mix of fields that the training should integrate, including basic biology and disease mechanisms, translational and clinical research concepts, data science approaches, behavioral research, and both traditional and emerging drug discovery and development disciplines. In practice, NIH is signaling that competitive programs will offer structured, cross-cutting curricula and mentored experiences that equip trainees to do rigorous, modern Alzheimer’s research, including skills like handling complex datasets, understanding disease pathways, designing translational studies, and navigating the steps that connect laboratory findings to therapeutic development.
Eligibility is broad and includes many types of U.S.-based organizations and government entities. Eligible applicants listed include state, county, and local governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; Native American tribal organizations that are not federally recognized; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations other than small businesses; and small businesses. The announcement also highlights additional eligible applicant categories such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, regional organizations, eligible federal agencies, and U.S. territories or possessions. At the same time, it clearly restricts foreign involvement at the applicant/component level: non-U.S. entities (foreign organizations and foreign institutions) are not eligible to apply, and non-U.S. components of U.S. organizations are also not eligible.
From an administrative standpoint, this is a discretionary grant in the health category (CFDA 93.866) offered by NIH. The record shows an original closing date of 2023-09-25 and a creation date of 2023-04-11. Award ceiling and expected number of awards are not specified in the provided listing, which typically means applicants should consult the full announcement text for budget structure, trainee slot guidance, allowable costs, and institute-specific priorities. Overall, the opportunity is designed to help institutions build durable, interdisciplinary training environments that can consistently produce researchers capable of advancing translational Alzheimer’s and ADRD science in a way that is methodologically strong, team-oriented, and responsive to the complexity of these diseases.Apply for PAR 23 163
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
- This funding opportunity was created on 2023-04-11.
- Applicants must submit their applications by 2023-09-25. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Health
Next opportunity: BLM IIJA Bureau of Land Management Alaska Wildlife Resources Program
Previous opportunity: FY 2023 Notice of Funding Opportunity for NGO programs benefiting refugees, asylum seekers, and vulnerable migrants in Costa Rica, Guatemala, Mexico, and Panama
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 23 163
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 23 163) also looked into and applied for these:
| Funding Opportunity |
|---|
| Centers of Excellence in Genomic Science (RM1 Clinical Trial Optional) Apply for PAR 23 098 Funding Number: PAR 23 098 Agency: National Institutes of Health Category: Health Funding Amount: $1,500,000 |
| Individually Measured Phenotypes to Advance Computational Translation in Mental Health (IMPACT-MH): Data Coordinating Center (U24 Clinical Trial Not Allowed) Apply for RFA MH 23 106 Funding Number: RFA MH 23 106 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Individually Measured Phenotypes to Advance Computational Translation in Mental Health (IMPACT-MH) (U01 Clinical Trial Optional) Apply for RFA MH 23 105 Funding Number: RFA MH 23 105 Agency: National Institutes of Health Category: Health Funding Amount: $2,500,000 |
| International Research in Infectious Diseases (R01 Clinical Trial Not Allowed) Apply for RFA AI 23 023 Funding Number: RFA AI 23 023 Agency: National Institutes of Health Category: Health Funding Amount: $125,000 |
| Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (UT1/UT2) Clinical Trial Not Allowed Apply for PAR 23 268 Funding Number: PAR 23 268 Agency: National Institutes of Health Category: Health Funding Amount: $295,924 |
| Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (U43/U44 Clinical Trials Not Allowed) Apply for PAR 23 267 Funding Number: PAR 23 267 Agency: National Institutes of Health Category: Health Funding Amount: $295,924 |
| Assay Development and Screening for Discovery of Validated Chemical Hits for Brain Disorders (R01 Clinical Trial Not Allowed) Apply for PAR 23 168 Funding Number: PAR 23 168 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Draft Notice of Funding Opportunity - Children, Adolescents, and Families in the HIV Epidemic in Free State Province Apply for 72067423RFI00003 Funding Number: 72067423RFI00003 Agency: South Africa USAID-Pretoria Category: Health Funding Amount: Case Dependent |
| Mentored Career Transition Award for Intramural Fellows (K22 Clinical Trials Not Allowed) Apply for PAR 23 149 Funding Number: PAR 23 149 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Mentored Career Transition Award for Intramural Fellows (K22 Clinical Trials Required) Apply for PAR 23 150 Funding Number: PAR 23 150 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Innovation for HIV Vaccine Discovery (R01 Clinical Trial Not Allowed) Apply for PAR 23 169 Funding Number: PAR 23 169 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| Synthetic Nucleic Acid Platforms for HIV-1 (SNAPH): (R61/R33 Clinical Trial Not Allowed) Apply for RFA AI 23 026 Funding Number: RFA AI 23 026 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research (R03 Clinical Trial Optional) Apply for PAR 23 179 Funding Number: PAR 23 179 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Maximizing Investigators Research Award (MIRA) for Early Stage Investigators (ESI) (R35 - Clinical Trial Optional) Apply for PAR 23 145 Funding Number: PAR 23 145 Agency: National Institutes of Health Category: Health Funding Amount: $275,000 |
| Nursing Home EXplanatory Clinical Trials Network (NEXT) (U24 Clinical Trial Required) Apply for RFA AG 24 016 Funding Number: RFA AG 24 016 Agency: National Institutes of Health Category: Health Funding Amount: $2,300,000 |
| Research on Bioethical Issues Related to Bionic and Robotic Device Development and Translation (R21 Clinical Trial Optional) Apply for RFA EB 23 005 Funding Number: RFA EB 23 005 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NEI Center Core Grant for Vision Research (P30 Clinical Trial Not Allowed) Apply for PAR 23 175 Funding Number: PAR 23 175 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| APS - Strengthening Health Services, Demand, and Systems in Benin Apply for 72068023APS00001 Funding Number: 72068023APS00001 Agency: Benin USAID-Cotonou Category: Health Funding Amount: $65,000,000 |
| NINDS Sustainable Transformation of Institutional Research Rigor (STIRR) Program (RC2 - Clinical Trial Not Allowed) Apply for RFA NS 24 020 Funding Number: RFA NS 24 020 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: Molecular Transducers of Physical Activity Chemical Analysis Sites (U24 Clinical Trial Not Allowed) Apply for RFA RM 23 021 Funding Number: RFA RM 23 021 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 23 163", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.